Media

Insights from Ron

Insights from Ron

2021 Cancer Highlights

2021 marked the 20th anniversary of the first human genome draft sequence, which led to such revolutionary landmarks as The ...
Read More →
Ron DePinho MD, on Telomeres in Cancer Aging Insights from Ron

Alzheimer’s Disease Research Makes a Paradigm Shift

In this study, we observed that Tert haploinsufficiency affected the expression of genes integral to AD pathogenesis and that neurons ...
Read More →
Insights from Ron

Tvardi Therapeutics: Fiercely Focused on STAT3 Inhibitors

According to life sciences publisher Fierce Biotech, what sets Tvardi Therapeutics apart from other early-stage biotech startups is that “it ...
Read More →

Cancer Research and Investment Opportunities

Cancer exacts a steep social and economic toll, especially as an aging world population creates increased cancer rates. The investment ...
Read More →

$74 million Series B Funding for Tvardi Therapeutics

As a Co-Founder and former Chairman of the Board I’m excited to announce that we’ve closed a $74 million Series ...
Read More →
Insights from Ron

Watch On-Demand Sessions: 2021 Fifth International Vatican Council

You can now view all of the speaker sessions from the May 6-8 Fifth International Vatican Conference on the conference website. ...
Read More →

Get Insights From Ron

Sign up for the latest news and updates from Ron DePinho, MD